173 related articles for article (PubMed ID: 23282952)
1. Twelve-hour ultrarush immunotherapy in a patient with mastocytosis and hymenoptera sting anaphylaxis.
Jäger D; Barth J
World Allergy Organ J; 2009 Mar; 2(3):37-9. PubMed ID: 23282952
[No Abstract] [Full Text] [Related]
2. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
González de Olano D; Alvarez-Twose I; Esteban-López MI; Sánchez-Muñoz L; de Durana MD; Vega A; García-Montero A; González-Mancebo E; Belver T; Herrero-Gil MD; Fernández-Rivas M; Orfao A; de la Hoz B; Castells MC; Escribano L
J Allergy Clin Immunol; 2008 Feb; 121(2):519-26. PubMed ID: 18177694
[TBL] [Abstract][Full Text] [Related]
3. Venom immunotherapy in indolent systemic mastocytosis with high serum tryptase level.
Selcuk A; Baysan A
Hum Vaccin Immunother; 2021 Jun; 17(6):1599-1603. PubMed ID: 33651660
[TBL] [Abstract][Full Text] [Related]
4. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy.
Haeberli G; Brönnimann M; Hunziker T; Müller U
Clin Exp Allergy; 2003 Sep; 33(9):1216-20. PubMed ID: 12956741
[TBL] [Abstract][Full Text] [Related]
5. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
6. One-day ultrarush desensitization for Hymenoptera venom anaphylaxis in patients with and without mast cell disorders with adjuvant omalizumab.
Giannetti M; Silver J; Hufdhi R; Castells M
J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1431-1435.e3. PubMed ID: 31704439
[No Abstract] [Full Text] [Related]
7. Mastocytosis and Hymenoptera venom allergy.
Ruëff F; Placzek M; Przybilla B
Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):284-8. PubMed ID: 16825870
[TBL] [Abstract][Full Text] [Related]
8. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
Bonadonna P; Zanotti R; Pagani M; Bonifacio M; Scaffidi L; Olivieri E; Franchini M; Reccardini F; Costantino MT; Roncallo C; Mauro M; Boni E; Rizzini FL; Bilò MB; Marcarelli AR; Passalacqua G
J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788
[TBL] [Abstract][Full Text] [Related]
9. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
[TBL] [Abstract][Full Text] [Related]
10. [Mastocytosis: an important differential diagnosis in anaphylactoid reaction to Hymenoptera sting. A case report and overview of clinical aspects, diagnosis and current therapy of mastocytosis].
Bucher C; Simic P; Furrer J; Wüthrich B
Praxis (Bern 1994); 2000 Mar; 89(10):411-8. PubMed ID: 10731856
[TBL] [Abstract][Full Text] [Related]
11. Fatal hymenoptera venom anaphylaxis by undetected clonal mast cell disorder: A better identification of high risk patients is needed.
Chatain C; Sedillot N; Thomas M; Pernollet M; Bocquet A; Boccon-Gibod I; Bouillet L; Leccia MT
Rev Med Interne; 2021 Dec; 42(12):869-874. PubMed ID: 34776279
[TBL] [Abstract][Full Text] [Related]
12. Update on Insect Sting Anaphylaxis.
Golden DBK
Curr Allergy Asthma Rep; 2021 Mar; 21(3):16. PubMed ID: 33666774
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients.
Niedoszytko M; Bonadonna P; Oude Elberink JN; Golden DB
Immunol Allergy Clin North Am; 2014 May; 34(2):365-81. PubMed ID: 24745680
[TBL] [Abstract][Full Text] [Related]
14. Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis.
Kors JW; van Doormaal JJ; de Monchy JG
J Intern Med; 1993 Mar; 233(3):255-8. PubMed ID: 8450293
[TBL] [Abstract][Full Text] [Related]
15. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
[TBL] [Abstract][Full Text] [Related]
16. Fatal anaphylactic sting reaction in a patient with mastocytosis.
Wagner N; Fritze D; Przybilla B; Hagedorn M; Ruëff F
Int Arch Allergy Immunol; 2008; 146(2):162-3. PubMed ID: 18204283
[TBL] [Abstract][Full Text] [Related]
17. Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis.
van Anrooij B; van der Veer E; de Monchy JG; van der Heide S; Kluin-Nelemans JC; van Voorst Vader PC; van Doormaal JJ; Oude Elberink JN
J Allergy Clin Immunol; 2013 Jul; 132(1):125-30. PubMed ID: 23498593
[TBL] [Abstract][Full Text] [Related]
18. Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema.
Stoevesandt J; Hain J; Kerstan A; Trautmann A
J Allergy Clin Immunol; 2012 Sep; 130(3):698-704.e1. PubMed ID: 22554708
[TBL] [Abstract][Full Text] [Related]
19. Hymenoptera venom allergy.
Przybilla B; Ruëff F
J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
[TBL] [Abstract][Full Text] [Related]
20. Insect Sting Anaphylaxis-Or Mastocytosis-Or Something Else?
Golden DBK; Carter MC
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1117-1123. PubMed ID: 30961837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
